Alx Oncology Holdings Inc. · NASDAQ:ALXO
Redmile Group, LLC reported a 8.50% stake in Alx Oncology Holdings Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Redmile Group, LLC reported a 8.50% stake in Alx Oncology Holdings Inc., 4,641,455 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 4,641,455
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 8.50% | 4,641,455 |
| Jeremy C. Green | 8.50% | 4,641,455 |
| Redmile Biopharma Investments III, L.P. | 6.70% | 3,675,481 |
Source
Related
- Alx Oncology Holdings Inc.
- Redmile Group, LLC
- Alx Oncology Holdings Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · May 15, 2026
- Schedule 13D/A · venBio Global Strategic Fund, L.P. · Oct 16, 2026
- Form 4 · Lettmann Jason · Aug 18, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026